NCT01924260 Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01916304 Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation Status COMPLETED Phase PHASE2
NCT01911091 Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus) Status ACTIVE_NOT_RECRUITING Phase NA
NCT01909934 Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Status COMPLETED Phase PHASE4
NCT01900522 Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia Status TERMINATED Phase PHASE1
NCT01892189 Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults Status COMPLETED Phase PHASE1
NCT01890122 Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01879722 Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants Status COMPLETED Phase PHASE1
NCT01861795 Observational Study in Preterm Neonates Who Are Sufficiently Stable on Non-Invasive Ventilatory Support Status COMPLETED Phase N/A
NCT01848210 Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous Insufficiency Status COMPLETED Phase PHASE4
NCT01834274 Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT01829477 Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT01829464 TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT01765426 Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector Status COMPLETED Phase PHASE1
NCT01763996 The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina Status COMPLETED Phase PHASE4